Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS in de Novo Kidney Transplant Recipients
NCT00312143Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Feb 2004; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00312143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312143.